The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cardiac Safety Services-Global Market Insights and Sales Trends 2024
Synopsis
Cardiac safety services can be defined as services that deal with supporting and designing clinical trials and other studies required for the monitoring of cardiac safety.Cardiac safety services are focused on monitoring the entire cardiac safety profile across various phases of clinical trials, including Phase I to Phase IV. These studies are done in compliance with FDA, PMDA, EMA, and other regulatory bodies.Cardiovascular safety assessment services include non-invasive cardiac imaging, physiologic stress testing, platelet aggregation, ambulatory blood pressure monitoring, and other services, along with the QT studies.Integrated services offering cardiac safety services are mostly preferred owing to the bundling of services with focus on end-to-end development, as compared to the specificity of standalone services
The global Cardiac Safety Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cardiac Safety Services in various end use industries. The expanding demands from the Pharmaceutical and Biopharmaceuticals Companies, Contract Research Organization(CRO) and Others,, are propelling Cardiac Safety Services market. Integrated Services, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Standalone Services segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cardiac Safety Services market, driven by demand from China, the second largest economy with some signs of stabilising, the Cardiac Safety Services market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cardiac Safety Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cardiac Safety Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cardiac Safety Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cardiac Safety Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cardiac Safety Services covered in this report include Biotrial, Banook Group, Bioclinica, Certara L.P., Celerion, Inc, ERT, Inc, Laboratory Corporation of America Holdings, Medpace Holdings, Inc. and Ncardia AG, etc.
The global Cardiac Safety Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biotrial
Banook Group
Bioclinica
Certara L.P.
Celerion, Inc
ERT, Inc
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Ncardia AG
Richmond Pharmacology
PhysioStim
IQVIA
BioTelemetry, Inc
Pharmaceutical Product Development, LLC
Shanghai Medicilon Inc
SGS SA
Spaulding Clinical Research, LLC
Global Cardiac Safety Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cardiac Safety Services market, Segment by Type:
by Type
Integrated Services
Standalone Services
by Service Type
Cardiovascular Imaging
Thorough QT studies
Blood Pressure Measurement
ECG Measurement
Others
Global Cardiac Safety Services market, by Application
Pharmaceutical and Biopharmaceuticals Companies
Contract Research Organization(CRO)
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cardiac Safety Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Cardiac safety services can be defined as services that deal with supporting and designing clinical trials and other studies required for the monitoring of cardiac safety.Cardiac safety services are focused on monitoring the entire cardiac safety profile across various phases of clinical trials, including Phase I to Phase IV. These studies are done in compliance with FDA, PMDA, EMA, and other regulatory bodies.Cardiovascular safety assessment services include non-invasive cardiac imaging, physiologic stress testing, platelet aggregation, ambulatory blood pressure monitoring, and other services, along with the QT studies.Integrated services offering cardiac safety services are mostly preferred owing to the bundling of services with focus on end-to-end development, as compared to the specificity of standalone services
The global Cardiac Safety Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cardiac Safety Services in various end use industries. The expanding demands from the Pharmaceutical and Biopharmaceuticals Companies, Contract Research Organization(CRO) and Others,, are propelling Cardiac Safety Services market. Integrated Services, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Standalone Services segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cardiac Safety Services market, driven by demand from China, the second largest economy with some signs of stabilising, the Cardiac Safety Services market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cardiac Safety Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cardiac Safety Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cardiac Safety Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cardiac Safety Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cardiac Safety Services covered in this report include Biotrial, Banook Group, Bioclinica, Certara L.P., Celerion, Inc, ERT, Inc, Laboratory Corporation of America Holdings, Medpace Holdings, Inc. and Ncardia AG, etc.
The global Cardiac Safety Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biotrial
Banook Group
Bioclinica
Certara L.P.
Celerion, Inc
ERT, Inc
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Ncardia AG
Richmond Pharmacology
PhysioStim
IQVIA
BioTelemetry, Inc
Pharmaceutical Product Development, LLC
Shanghai Medicilon Inc
SGS SA
Spaulding Clinical Research, LLC
Global Cardiac Safety Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cardiac Safety Services market, Segment by Type:
by Type
Integrated Services
Standalone Services
by Service Type
Cardiovascular Imaging
Thorough QT studies
Blood Pressure Measurement
ECG Measurement
Others
Global Cardiac Safety Services market, by Application
Pharmaceutical and Biopharmaceuticals Companies
Contract Research Organization(CRO)
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cardiac Safety Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cardiac Safety Services
1.1 Cardiac Safety Services Market Overview
1.1.1 Cardiac Safety Services Product Scope
1.1.2 Cardiac Safety Services Market Status and Outlook
1.2 Global Cardiac Safety Services Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cardiac Safety Services Market Size by Region (2018-2029)
1.4 Global Cardiac Safety Services Historic Market Size by Region (2018-2023)
1.5 Global Cardiac Safety Services Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cardiac Safety Services Market Size (2018-2029)
1.6.1 North America Cardiac Safety Services Market Size (2018-2029)
1.6.2 Europe Cardiac Safety Services Market Size (2018-2029)
1.6.3 Asia-Pacific Cardiac Safety Services Market Size (2018-2029)
1.6.4 Latin America Cardiac Safety Services Market Size (2018-2029)
1.6.5 Middle East & Africa Cardiac Safety Services Market Size (2018-2029)
2 Cardiac Safety Services Market by Type
2.1 Introduction
2.1.1 Integrated Services
2.1.2 Standalone Services
2.2 Global Cardiac Safety Services Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cardiac Safety Services Historic Market Size by Type (2018-2023)
2.2.2 Global Cardiac Safety Services Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cardiac Safety Services Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cardiac Safety Services Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cardiac Safety Services Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cardiac Safety Services Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cardiac Safety Services Revenue Breakdown by Type (2018-2029)
3 Cardiac Safety Services Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical and Biopharmaceuticals Companies
3.1.2 Contract Research Organization(CRO)
3.1.3 Others
3.2 Global Cardiac Safety Services Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cardiac Safety Services Historic Market Size by Application (2018-2023)
3.2.2 Global Cardiac Safety Services Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cardiac Safety Services Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cardiac Safety Services Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cardiac Safety Services Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cardiac Safety Services Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cardiac Safety Services Revenue Breakdown by Application (2018-2029)
4 Cardiac Safety Services Competition Analysis by Players
4.1 Global Cardiac Safety Services Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cardiac Safety Services as of 2022)
4.3 Date of Key Players Enter into Cardiac Safety Services Market
4.4 Global Top Players Cardiac Safety Services Headquarters and Area Served
4.5 Key Players Cardiac Safety Services Product Solution and Service
4.6 Competitive Status
4.6.1 Cardiac Safety Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biotrial
5.1.1 Biotrial Profile
5.1.2 Biotrial Main Business
5.1.3 Biotrial Cardiac Safety Services Products, Services and Solutions
5.1.4 Biotrial Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.1.5 Biotrial Recent Developments
5.2 Banook Group
5.2.1 Banook Group Profile
5.2.2 Banook Group Main Business
5.2.3 Banook Group Cardiac Safety Services Products, Services and Solutions
5.2.4 Banook Group Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.2.5 Banook Group Recent Developments
5.3 Bioclinica
5.3.1 Bioclinica Profile
5.3.2 Bioclinica Main Business
5.3.3 Bioclinica Cardiac Safety Services Products, Services and Solutions
5.3.4 Bioclinica Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.3.5 Certara L.P. Recent Developments
5.4 Certara L.P.
5.4.1 Certara L.P. Profile
5.4.2 Certara L.P. Main Business
5.4.3 Certara L.P. Cardiac Safety Services Products, Services and Solutions
5.4.4 Certara L.P. Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.4.5 Certara L.P. Recent Developments
5.5 Celerion, Inc
5.5.1 Celerion, Inc Profile
5.5.2 Celerion, Inc Main Business
5.5.3 Celerion, Inc Cardiac Safety Services Products, Services and Solutions
5.5.4 Celerion, Inc Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.5.5 Celerion, Inc Recent Developments
5.6 ERT, Inc
5.6.1 ERT, Inc Profile
5.6.2 ERT, Inc Main Business
5.6.3 ERT, Inc Cardiac Safety Services Products, Services and Solutions
5.6.4 ERT, Inc Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.6.5 ERT, Inc Recent Developments
5.7 Laboratory Corporation of America Holdings
5.7.1 Laboratory Corporation of America Holdings Profile
5.7.2 Laboratory Corporation of America Holdings Main Business
5.7.3 Laboratory Corporation of America Holdings Cardiac Safety Services Products, Services and Solutions
5.7.4 Laboratory Corporation of America Holdings Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.7.5 Laboratory Corporation of America Holdings Recent Developments
5.8 Medpace Holdings, Inc.
5.8.1 Medpace Holdings, Inc. Profile
5.8.2 Medpace Holdings, Inc. Main Business
5.8.3 Medpace Holdings, Inc. Cardiac Safety Services Products, Services and Solutions
5.8.4 Medpace Holdings, Inc. Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.8.5 Medpace Holdings, Inc. Recent Developments
5.9 Ncardia AG
5.9.1 Ncardia AG Profile
5.9.2 Ncardia AG Main Business
5.9.3 Ncardia AG Cardiac Safety Services Products, Services and Solutions
5.9.4 Ncardia AG Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.9.5 Ncardia AG Recent Developments
5.10 Richmond Pharmacology
5.10.1 Richmond Pharmacology Profile
5.10.2 Richmond Pharmacology Main Business
5.10.3 Richmond Pharmacology Cardiac Safety Services Products, Services and Solutions
5.10.4 Richmond Pharmacology Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.10.5 Richmond Pharmacology Recent Developments
5.11 PhysioStim
5.11.1 PhysioStim Profile
5.11.2 PhysioStim Main Business
5.11.3 PhysioStim Cardiac Safety Services Products, Services and Solutions
5.11.4 PhysioStim Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.11.5 PhysioStim Recent Developments
5.12 IQVIA
5.12.1 IQVIA Profile
5.12.2 IQVIA Main Business
5.12.3 IQVIA Cardiac Safety Services Products, Services and Solutions
5.12.4 IQVIA Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.12.5 IQVIA Recent Developments
5.13 BioTelemetry, Inc
5.13.1 BioTelemetry, Inc Profile
5.13.2 BioTelemetry, Inc Main Business
5.13.3 BioTelemetry, Inc Cardiac Safety Services Products, Services and Solutions
5.13.4 BioTelemetry, Inc Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.13.5 BioTelemetry, Inc Recent Developments
5.14 Pharmaceutical Product Development, LLC
5.14.1 Pharmaceutical Product Development, LLC Profile
5.14.2 Pharmaceutical Product Development, LLC Main Business
5.14.3 Pharmaceutical Product Development, LLC Cardiac Safety Services Products, Services and Solutions
5.14.4 Pharmaceutical Product Development, LLC Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.14.5 Pharmaceutical Product Development, LLC Recent Developments
5.15 Shanghai Medicilon Inc
5.15.1 Shanghai Medicilon Inc Profile
5.15.2 Shanghai Medicilon Inc Main Business
5.15.3 Shanghai Medicilon Inc Cardiac Safety Services Products, Services and Solutions
5.15.4 Shanghai Medicilon Inc Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.15.5 Shanghai Medicilon Inc Recent Developments
5.16 SGS SA
5.16.1 SGS SA Profile
5.16.2 SGS SA Main Business
5.16.3 SGS SA Cardiac Safety Services Products, Services and Solutions
5.16.4 SGS SA Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.16.5 SGS SA Recent Developments
5.17 Spaulding Clinical Research, LLC
5.17.1 Spaulding Clinical Research, LLC Profile
5.17.2 Spaulding Clinical Research, LLC Main Business
5.17.3 Spaulding Clinical Research, LLC Cardiac Safety Services Products, Services and Solutions
5.17.4 Spaulding Clinical Research, LLC Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.17.5 Spaulding Clinical Research, LLC Recent Developments
6 North America
6.1 North America Cardiac Safety Services Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cardiac Safety Services Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Safety Services Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cardiac Safety Services Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Safety Services Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cardiac Safety Services Market Dynamics
11.1 Cardiac Safety Services Industry Trends
11.2 Cardiac Safety Services Market Drivers
11.3 Cardiac Safety Services Market Challenges
11.4 Cardiac Safety Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
